167 related articles for article (PubMed ID: 34625644)
61. Comprehensive analysis of circulating cell-free RNAs in blood for diagnosing non-small cell lung cancer.
Liu Y; Liang Y; Li Q; Li Q
Comput Struct Biotechnol J; 2023; 21():4238-4251. PubMed ID: 37692082
[TBL] [Abstract][Full Text] [Related]
62. Erlotinib efficacy and cerebrospinal fluid concentration in patients with lung adenocarcinoma developing leptomeningeal metastases during gefitinib therapy.
Masuda T; Hattori N; Hamada A; Iwamoto H; Ohshimo S; Kanehara M; Ishikawa N; Fujitaka K; Haruta Y; Murai H; Kohno N
Cancer Chemother Pharmacol; 2011 Jun; 67(6):1465-9. PubMed ID: 21274533
[TBL] [Abstract][Full Text] [Related]
63. CSF cell-free DNA EGFR testing using DdPCR holds promise over conventional modalities for diagnosing leptomeningeal involvement in patients with non-small cell lung cancer.
Suryavanshi M; Jaipuria J; Panigrahi MK; Goyal N; Singal R; Mehta A; Batra U; Doval DC; Talwar V
Lung Cancer; 2020 Oct; 148():33-39. PubMed ID: 32784073
[TBL] [Abstract][Full Text] [Related]
64. Deep Learning-Based Classification of Cancer Cell in Leptomeningeal Metastasis on Cytomorphologic Features of Cerebrospinal Fluid.
Yu W; Liu Y; Zhao Y; Huang H; Liu J; Yao X; Li J; Xie Z; Jiang L; Wu H; Cao X; Zhou J; Guo Y; Li G; Ren MX; Quan Y; Mu T; Izquierdo GA; Zhang G; Zhao R; Zhao D; Yan J; Zhang H; Lv J; Yao Q; Duan Y; Zhou H; Liu T; He Y; Bian T; Dai W; Huai J; Wang X; He Q; Gao Y; Ren W; Niu G; Zhao G
Front Oncol; 2022; 12():821594. PubMed ID: 35273914
[TBL] [Abstract][Full Text] [Related]
65. [Analysis of Clinicopathological Feature and Prognosis for
Leptomeningeal Metastasis in Non-small Cell Lung Cancer].
Zhu M; Ren Y; Liu Y; Ban C; Gu H; Wang Z; Zhang Y
Zhongguo Fei Ai Za Zhi; 2016 Aug; 19(8):533-8. PubMed ID: 27561804
[TBL] [Abstract][Full Text] [Related]
66. Successful treatment using targeted therapy, radiotherapy, and intrathecal chemotherapy in a patient with leptomeningeal metastasis with an epidermal growth factor receptor exon 20 insertion mutation: a case report.
Ma Y; Liu H; Zhang M; Liu B; Ding Q; Zhang L; Guo L; Liu M
Ann Palliat Med; 2022 Apr; 11(4):1533-1541. PubMed ID: 34263612
[TBL] [Abstract][Full Text] [Related]
67. Treatment response to intrathecal chemotherapy with pemetrexed via an Ommaya reservoir in EGFR-mutated leptomeningeal metastases from non-small cell lung cancer: a case report.
Li H; Lin Y; Yu T; Xie Y; Feng J; Huang M; Guo A; Liu X; Yin Z
Ann Palliat Med; 2020 Jul; 9(4):2341-2346. PubMed ID: 32648459
[TBL] [Abstract][Full Text] [Related]
68. Experimental Assessment of Leptomeningeal Metastasis Diagnosis in Medulloblastoma Using Cerebrospinal Fluid Metabolomic Profiles.
Im JH; Yoo BC; Lee JH; Lee KY; Kim KH; Kim JH; Park HJ; Park M; Lee SH; Kwon JW; Shin SH; Yoo H; Yang J; Choi SA; Kim SK; Gwak HS
Metabolites; 2021 Dec; 11(12):. PubMed ID: 34940608
[TBL] [Abstract][Full Text] [Related]
69. Prospective study revealed prognostic significance of responses in leptomeningeal metastasis and clinical value of cerebrospinal fluid-based liquid biopsy.
Xu Y; Hu M; Zhang M; Zhong W; Yin X; Sun Y; Chen M; Zhao J; Si X; Wang H; Zhang X; Zhang L; Li J; Guan H; Yang Z; Wang M
Lung Cancer; 2018 Nov; 125():142-149. PubMed ID: 30429013
[TBL] [Abstract][Full Text] [Related]
70. A non-small cell lung cancer (NSCLC) patient with leptomeningeal metastasis harboring rare epidermal growth factor receptor (EGFR) mutations G719S and L861Q benefited from doubling dosage of osimertinib: a case report.
Shan CG; Wang H; Lin T; Liu D; Wen L; Chen ZJ; Zhen JJ; Lai MY; Zhang L; Zou X; Hong WP; Cai LB
Ann Palliat Med; 2021 May; 10(5):5897-5901. PubMed ID: 33977730
[TBL] [Abstract][Full Text] [Related]
71. Cerebrospinal fluid circulating tumor cells as a quantifiable measurement of leptomeningeal metastases in patients with HER2 positive cancer.
Malani R; Fleisher M; Kumthekar P; Lin X; Omuro A; Groves MD; Lin NU; Melisko M; Lassman AB; Jeyapalan S; Seidman A; Skakodub A; Boire A; DeAngelis LM; Rosenblum M; Raizer J; Pentsova E
J Neurooncol; 2020 Jul; 148(3):599-606. PubMed ID: 32506369
[TBL] [Abstract][Full Text] [Related]
72. Novel method for the detection and quantification of malignant cells in the CSF of patients with leptomeningeal metastasis of lung cancer.
Ma C; Lv Y; Jiang R; Li J; Wang B; Sun L
Oncol Lett; 2016 Jan; 11(1):619-623. PubMed ID: 26870256
[TBL] [Abstract][Full Text] [Related]
73. Epidermal Growth Factor Receptor Mutation Detection in Cerebrospinal Fluid of Lung Adenocarcinoma Patients with Leptomeningeal Metastasis.
Huang R; Ge M; Zhou X; Ji X; Liao L; Liang X; Zhan Q
Cancer Biother Radiopharm; 2019 Mar; 34(2):128-133. PubMed ID: 30452286
[TBL] [Abstract][Full Text] [Related]
74. Migration and invasion of NSCLC suppressed by the downregulation of Src/focal adhesion kinase using single, double and tetra domain anti- CEACAM6 antibodies.
Wu SJ; Arundhathi A; Wang HC; Chen CY; Cheng TM; Yuan SF; Wang YM
Transl Oncol; 2021 Jul; 14(7):101057. PubMed ID: 33934053
[TBL] [Abstract][Full Text] [Related]
75. Whole brain radiation therapy does not improve the overall survival of EGFR-mutant NSCLC patients with leptomeningeal metastasis.
Yan W; Liu Y; Li J; Han A; Kong L; Yu J; Zhu H
Radiat Oncol; 2019 Sep; 14(1):168. PubMed ID: 31521171
[TBL] [Abstract][Full Text] [Related]
76. CSF protein profiling using Multiplex Immuno-assay: A potential new diagnostic tool for leptomeningeal metastases.
Brandsma D; Voest EE; de Jager W; Bonfrer H; Algra A; Boogerd W; Korse T; Reijneveld JC; Verbeek MM; Rijkers G; Taphoorn MJ
J Neurol; 2006 Sep; 253(9):1177-84. PubMed ID: 16998648
[TBL] [Abstract][Full Text] [Related]
77. Clinical efficacy analysis of Osimertinib treatment for a patient with leptomeningeal metastasis of EGFR+ non-small cell lung cancer without the T790M mutation.
Hu X; Chen W; Li X; Zhao C; Zhang C; Xiong F; Wu H
Ann Palliat Med; 2019 Nov; 8(5):525-531. PubMed ID: 31865717
[TBL] [Abstract][Full Text] [Related]
78. A phase I trial of high dose gefitinib for patients with leptomeningeal metastases from non-small cell lung cancer.
Jackman DM; Cioffredi LA; Jacobs L; Sharmeen F; Morse LK; Lucca J; Plotkin SR; Marcoux PJ; Rabin MS; Lynch TJ; Johnson BE; Kesari S
Oncotarget; 2015 Feb; 6(6):4527-36. PubMed ID: 25784657
[TBL] [Abstract][Full Text] [Related]
79. Prolonged survival of patients with non-small-cell lung cancer with leptomeningeal carcinomatosis in the modern treatment era.
Riess JW; Nagpal S; Iv M; Zeineh M; Gubens MA; Ramchandran K; Neal JW; Wakelee HA
Clin Lung Cancer; 2014 May; 15(3):202-6. PubMed ID: 24524822
[TBL] [Abstract][Full Text] [Related]
80. Comparison of the diagnostic value of liquid biopsy in leptomeningeal metastases: A systematic review and meta-analysis.
Wang H; Wang L; Fang C; Li C; Zhang L
Front Oncol; 2022; 12():1079796. PubMed ID: 36601482
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
